Development of Dalbavancin, a glycopeptide anti-bacterial agent
Location: United States, Illinois, Chicago
Investors 4
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Aisling Ca... | aislingcap... |
| - | Vivo Capit... | vivocapita... |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 04.12.2012 | New broad-... | The drug has been tested in mo... | - | - | medcitynew... |
| 14.11.2012 | Little Dur... | Fresh from raising $74 million... | Clinical D... | - | fiercebiot... |
| - | New broad-... | Three years ago, Yale Universi... | - | - | medcitynew... |